A Phase 1 Study to Evaluate the Pharmacokinetics of Roxadustat in Subjects With Different Degrees of Renal Function

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

09 Nov 2020 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
19 Oct 2020 According to a FibroGen media release, data form this study will be presented at the American Society of Nephrology (ASN) Kidney Week 2020.
08 Jun 2020 According to an Astellas Pharma media release, results from this study were presented at the European Renal Association-European Dialysis and Transplant Association Virtual Congress 2020.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com